Director, Alliance Management, Business Development & Licensing at Novartis Institutes for BioMedical Research (NIBR)
Cambridge, Massachusetts
Regulatory Medical Writer; Scientific Publications Lead @ Sanofi Lead Regulatory Medical Writer, then transitioned to Global Medical Affairs managing scientific publications for Oncology products From 2010 to January 2013 (3 years) Cambridge, MAClinical Development Scientist @ ARIAD Pharmaceuticals, Inc. From January 2013 to 2014 (1 year) Cambridge, MAMember Board of Directors @ WEST - Women in the...
Regulatory Medical Writer; Scientific Publications Lead @ Sanofi Lead Regulatory Medical Writer, then transitioned to Global Medical Affairs managing scientific publications for Oncology products From 2010 to January 2013 (3 years) Cambridge, MAClinical Development Scientist @ ARIAD Pharmaceuticals, Inc. From January 2013 to 2014 (1 year) Cambridge, MAMember Board of Directors @ WEST - Women in the Enterprise of Science and Technology Member of Board of Directors and Advisory Board of WEST Greater Boston AreaSenior Clinical Research Scientist @ Deciphera Pharmaceuticals Deciphera is inspired to improve treatment for patients with cancer by designing kinase inhibitor therapies that target multiple hallmarks of cancer.Clinical input in all translational medicine research activities.Supporting Clinical Advisory Boards. From September 2014 to September 2015 (1 year 1 month) Cambridge, MAAdjunct Research Investigator, Harvard Global Equity Initiative @ Harvard University ·Initiate and develop international clinical education programs for medical oncologists at Harvard-affiliated hospitals; invited delegate at LIVESTRONG Global Cancer Summit; speaker at “Breast Cancer in the Developing World Global Symposium.”·Design community outreach and public health programs focused on increasing early breast cancer detection in resource-limited settings; analyze screening mammography use vs. other cancer detection modalities in developing/low resource countries.·Develop medical presentations and lead research training workshops/symposia on cancer biomarkers, advances in cancer treatments and clinical trial findings in collaboration with the Dana-Farber/Harvard Cancer Center. From September 2008 to September 2010 (2 years 1 month) Greater Boston AreaTranslational Medicine/Cancer Biology, Postdoctoral Research Associate @ Harvard Medical School ·Multidisciplinary NCI-designated Specialized Program of Research Excellence (SPORE) in Breast Cancer at Harvard.·Planned and led research meetings with laboratory investigators; presented progress reports and analyzed research data to be presented at multidisciplinary monthly SPORE meetings. · Designed, planned and performed all research tasks for functional Genome Wide Association Studies.Multidisciplinary training program in Environmental Epidemiology. Completed coursework in Biostatistics and Epidemiological Analyses. Contributed as a first author to a white paper report for the National Institute of Environmental Health Sciences on human safety of environmental endocrine disrupting compounds. The report was used by the FDA in developing regulatory guidelines for such compounds. From July 2006 to September 2010 (4 years 3 months) Associate Director, Business Development and Licensing/Strategic Alliances @ Novartis Institutes for BioMedical Research (NIBR) From October 2017 to April 2020 (2 years 7 months) Cambridge, MADirector, Alliance Management, Business Development & Licensing @ Novartis Institutes for BioMedical Research (NIBR) Cambridge, Massachusetts, United StatesAssociate Director, Clinical Scientist Oncology @ Baxalta Baxalta Oncology, now ShireImmuno-oncology lead clinical scientist and Collaboration Program Leader. Managing clinical-stage IO program partnerships / biotech alliances. Contributions to FDA filings and final approval of Calaspargase Pegol (Asparlas) for pediatric and young adult patients with ALL From September 2015 to October 2017 (2 years 2 months) Cambridge, MA
Sanofi
Regulatory Medical Writer; Scientific Publications Lead
2010 to January 2013
Cambridge, MA
ARIAD Pharmaceuticals, Inc.
Clinical Development Scientist
January 2013 to 2014
Cambridge, MA
WEST - Women in the Enterprise of Science and Technology
Member Board of Directors
Greater Boston Area
Deciphera Pharmaceuticals
Senior Clinical Research Scientist
September 2014 to September 2015
Cambridge, MA
Harvard University
Adjunct Research Investigator, Harvard Global Equity Initiative
September 2008 to September 2010
Greater Boston Area
Harvard Medical School
Translational Medicine/Cancer Biology, Postdoctoral Research Associate
July 2006 to September 2010
Novartis Institutes for BioMedical Research (NIBR)
Associate Director, Business Development and Licensing/Strategic Alliances
October 2017 to April 2020
Cambridge, MA
Novartis Institutes for BioMedical Research (NIBR)
Director, Alliance Management, Business Development & Licensing
Cambridge, Massachusetts, United States
Baxalta
Associate Director, Clinical Scientist Oncology
September 2015 to October 2017
Cambridge, MA
Harvard Medical School
post-doctorate, Molecular Oncology
2006 to 2010
Harvard T.H. Chan School of Public Health
Training program in Molecular Epidemiology
2006 to 2007
University of Cincinnati College of Medicine
Ph.D., Molecular Biology of Cancer
2000 to 2005
University of Pittsburgh
B.S., Honors Program in Biological Sciences and Women's Studies
1994 to 1997
Lead Regulatory Medical Writer, then transitioned to Global Medical Affairs managing scientific publications for Oncology products Lead Regulatory Medical Writer, then transitioned to Global Medical Affairs managing scientific publications for Oncology products
What company does Yelena Wetherill work for?
Yelena Wetherill works for Sanofi
What is Yelena Wetherill's role at Sanofi?
Yelena Wetherill is Regulatory Medical Writer; Scientific Publications Lead
What industry does Yelena Wetherill work in?
Yelena Wetherill works in the Pharmaceuticals industry.
Enjoy unlimited access and discover candidates outside of LinkedIn
One billion email addresses and counting
Everything you need to engage with more prospects.
ContactOut is used by
76% of Fortune 500 companies
Yelena Wetherill's Social Media Links
/school/ha... /company/n...